Abstract Background The Nelson mortality results were presented in September 2018. Four
other randomized control trials (RCTs) were also reported the latest mortality outcomes in …

PURPOSE This meta-analysis aims to combine and analyze randomized clinical trials
comparing computed tomography lung screening (CTLS) versus either no screening (NS) or …

Randomised clinical trials have shown the efficacy of computed tomography lung cancer
screening, initiating discussions on whether and how to implement population‐based …

Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined.
Nevertheless, population‐based lung cancer screening is still not considered standard …

Lung cancer is the leading cause of all cancer deaths worldwide, comprising 18.4% of all
cancer deaths. Low-dose computed tomography (LDCT) has shown mortality benefit in …

Lung cancer accounts for an alarming human and economic burden in low-and middle-
income countries (LMICs). Recent landmark trials from high-income countries (HICs) by …

Lung cancer continues to be one of the main causes of cancer death in Europe. Low-dose
computed tomography (LDCT) has shown high potential for screening of lung cancer in …

Lung cancer is the leading cause of cancer death worldwide, comprising almost 20% of all
cancer deaths. The concept of screening for lung cancer using low-dose computed …

Lung cancer is associated with a heavy cancer-related burden in terms of patients' physical
and mental health worldwide. Two randomized controlled trials, the US-National Lung …

Pulmonary nodules are often encountered by respiratory physicians, radiologists and
thoracic surgeons alike. The European Association of Cardio-Thoracic Surgery and the …